Dr. Jen wrote on:17 alpha hydroxyprogesterone 17OP aluminum cerebral palsy congenital heart defect congenital heart disease disability eating disorder fine motor skill fine motor skills flu going home hands health insurance hypotonia influenza KV Pharmaceuticals losing a baby Makena March of Dimes medicaid NEC NICU omega-3 OT perseverance pertussis Play-Doh preeclampsia preemie progesterone RediWhip RSV running safety stress Synagis Tae Kwon Do tests Thanksgiving turkey vaccine vaccines whooping cough writing
- Preventing prematurity: the importance of getting screened for Chlamydia
- Ther-Rx skips ACOG: the people have spoken. But can we do more?
- What does replacing the word retarded with intellectual disability accomplish?
- Cigna’s automatic denials: asshattery in action
- ACOG’s double standard on Makena: denouncing Ther-Rx but taking advertising dollars
Tag Archives: March of Dimes
It started in February. KV Pharmaceuticals submitted an application to the FDA to make Makena (17 hydroxyprogesterone or 17OP) an orphan drug. The application was endorsed by the March of Dimes. The actual quote from the medical director of the … Continue reading
Rep. Henry Waxman, Rep. Frank Pallone, Jr., and Rep. Diana DeGette sent a letter on March 24th to Gregory Divis, the CEO of Ther-Rx, regarding the pricing of Makena (see below). Of note, the honorable Mr. Waxman, Mr. Pallone, Jr, and Ms. … Continue reading
Today (March 23rd) Dr. Jennifer Howse of the March of Dimes (MOD) finally responded to the egregious price gouging/extortion that is Makena (17 Alpha-hydroxyprogesterone caproate, or 17OP, newly packaged as an orphan drug). As we all know, this travesty was … Continue reading
This whole Makena thing just keeps getting worse. Worse for women, because co-payments have sky rocketed and worse for the March of Dimes, whose every move proves they are just digging themselves a deeper hole. I read yesterday (March 22) … Continue reading
The senior vice president (SVP) of marketing for the March of Dimes (MOD) reached out to me via e-mail on Monday about Makena pricing. He wanted to let me know the March of Dimes is “doing all we can to ensure access for … Continue reading
Makena, KV Pharmaceuticals version of 17 alpha-hydroxyprogesterone caproate or 17OP (for prevention of preterm labor) is priced at $1500 a shot (up from $10 a shot prior to the meddling of the FDA). Considering most women who are eligible will … Continue reading
Preemie message boards are all fired up by KV Pharmaceutical’s pricing of 17 Alpha-hydroxy progesterone caproate (17P, a hormone than can help prevent premature delivery for some women who have previously delivered prematurely). Once KV was awarded the patent, the … Continue reading